Accelerate Faster To Market With Assurance From A Vaccine Ready Network

mRNA vaccines and therapeutics have complex manufacturing supply chains that require industry knowledge and experience to successfully navigate from clinical to commercialization. Marken’s global Vaccine Ready Network is strategically agile and prepared to safeguard your vaccine trial with fewer hand-offs, shorter turnaround times, all while maintaining complete transparency and end-to-end visibility along each step of the way.

Working with over 140 Covid-19 vaccine clinical trials during the course of the pandemic, Marken has successfully proven our experience and knowledge to ensure vaccines in development are delivered within specifications and time. Marken’s dedicated start-up team is available 24/7/365, with flexible solutions and contingency plans in place to mitigate supply chain disruptions and guarantee efficient and secure vaccine distribution for all patients.